Meeting of the Board of Directors scheduled for Tuesday, 27th October 2026
To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended 30th September 2026, along with Limited Review Reports
To consider and evaluate proposal for raising funds by way of issuance of eligible securities of the Company
Fundraising Details
Proposed to be raised in one or more tranches
Through one or more public and/or private offerings
Potential methods include: Private Placement/Preferential Issue, Qualified Institutions Placement, and/or further public offering
To be conducted in accordance with Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (each as amended)
May be through any other permissible mode or combination thereof
Manner to be decided by the Board
Subject to statutory/regulatory approvals including shareholder approval wherever required
Shareholder Meeting
Extraordinary General Meeting (EOGM) may be conducted to seek shareholder approval for the fundraising proposal
EOGM contingent upon Board approval of the fundraising proposal
Trading Window Status
Trading window for dealing in Company's shares is already closed
Closure period: Until 48 hours after declaration of Unaudited Standalone and Consolidated Financial Results along with Limited Review Reports for quarter and half-year ended 30th September 2026
Compliance with SEBI (Prohibition of Insider Trading) Regulations 2015 (including amendments thereto)
